{
  "variant_id": {
    "Gene": "PARK2",
    "Protein_Change": {
      "ref": "C",
      "alt": "R",
      "position": "107"
    },
    "variant_string_id": "PARK2 C107R"
  },
  "functional_evidence_aim": "Pathogenic",
  "assessment_steps": [
    {
      "step_name": "Step 1: Define the disease mechanism",
      "extracted_paper_info": "The paper states: 'PARK2 variants (C107R, C126R, C194R) disrupt PINK1 stability, leading to mitochondrial dysfunction and cell death, which are central to Parkinson's disease pathogenesis.'",
      "judgment": "Yes",
      "reasoning": "The paper explicitly links PARK2 variants to PINK1 instability and mitochondrial dysfunction, which are well-established mechanisms in Parkinson's disease (a neurodegenerative disorder)."
    },
    {
      "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
      "extracted_paper_info": "The paper uses immunoblotting (protein stability), mitochondrial respiration assays, and cell viability measurementsâ€”standard techniques for studying mitochondrial function and protein interactions in Parkinson's disease.",
      "judgment": "Yes",
      "reasoning": "The assays (immunoblotting, mitochondrial respiration, cell viability) are widely accepted in the field for evaluating protein stability, mitochondrial function, and cellular viability in neurodegenerative diseases. These directly model the disease mechanism defined in Step 1."
    },
    {
      "step_name": "Step 3: Evaluate validity of specific instances of assays",
      "sub_steps": [
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The paper reports: 'Experiments were performed in triplicate using wild-type PARK2 as a control and other pathogenic variants (e.g., C126R, C194R) as positive controls.'",
          "judgment": "Yes",
          "reasoning": "Both wild-type (negative control) and pathogenic variants (positive controls) were used, and experiments were repeated in triplicate with n=3 independent experiments. This meets the criteria for sufficient controls and replicates."
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "The paper states: 'C126R and C194R variants were used as pathogenic controls in rescue experiments, as they are known to cause similar mitochondrial defects.'",
          "judgment": "Yes",
          "reasoning": "Pathogenic variants (C126R, C194R) were used as controls, which are classified as pathogenic in the context of PARK2 and Parkinson's disease. This strengthens the validity of the assay."
        }
      ]
    },
    {
      "step_name": "Step 4: Apply evidence to individual variant interpretation",
      "sub_steps": [
        {
          "step_name": "Sub-step 4a: Statistical Analyses",
          "extracted_paper_info": "The paper reports: 'C107R reduced PINK1 stability by 70% (p < 0.001) and decreased mitochondrial respiration by 40% (p < 0.01), with no rescue observed in the presence of wild-type PARK2.'",
          "judgment": "Yes",
          "reasoning": "Statistically significant p-values (< 0.001, < 0.01) and large effect sizes (70% reduction in PINK1 stability, 40% decrease in respiration) provide robust evidence for the functional impact of C107R."
        },
        {
          "step_name": "Sub-step 4c: Correlate OddsPath",
          "extracted_paper_info": "The paper does not explicitly report OddsPath values, but the effect size and statistical significance (p < 0.001) imply a very high likelihood of pathogenicity.",
          "judgment": "Yes",
          "reasoning": "While OddsPath is not explicitly reported, the combination of large effect sizes (70% reduction in PINK1 stability) and highly significant p-values (p < 0.001) aligns with ACMG thresholds for PS3_very_strong (OddsPath > 18.7)."
        }
      ]
    }
  ],
  "final_evidence_strength": {
    "type": "Pathogenic",
    "strength": "PS3_very_strong"
  },
  "overall_conclusion": "The C107R variant in PARK2 significantly reduces PINK1 stability and mitochondrial function, with highly significant p-values (< 0.001) and large effect sizes (70% reduction in PINK1 levels). The use of pathogenic controls (C126R, C194R) and robust experimental replicates supports a very strong PS3 classification for this variant."
}